ANL 0.00 No Change ▼ 0.00 (0%)
ASC 0.00 Decreased By ▼ -13.22 (-100%)
ASL 0.00 Decreased By ▼ -17.53 (-100%)
BOP 0.00 Decreased By ▼ -8.65 (-100%)
BYCO 0.00 Decreased By ▼ -7.29 (-100%)
FCCL 0.00 Decreased By ▼ -19.10 (-100%)
FFBL 0.00 No Change ▼ 0.00 (0%)
FFL 0.00 No Change ▼ 0.00 (0%)
FNEL 0.00 No Change ▼ 0.00 (0%)
GGGL 0.00 No Change ▼ 0.00 (0%)
GGL 30.00 Increased By ▲ 2.11 (7.57%)
HUMNL 6.65 Decreased By ▼ -0.13 (-1.92%)
JSCL 0.00 Decreased By ▼ -19.25 (-100%)
KAPCO 0.00 Decreased By ▼ -27.25 (-100%)
KEL 0.00 Decreased By ▼ -3.34 (-100%)
MDTL 0.00 No Change ▼ 0.00 (0%)
MLCF 34.25 Increased By ▲ 34.25 (0%)
NETSOL 0.00 No Change ▼ 0.00 (0%)
PACE 0.00 No Change ▼ 0.00 (0%)
PAEL 0.00 Decreased By ▼ -26.49 (-100%)
PIBTL 0.00 No Change ▼ 0.00 (0%)
POWER 0.00 No Change ▼ 0.00 (0%)
PRL 15.80 Increased By ▲ 15.80 (0%)
PTC 0.00 No Change ▼ 0.00 (0%)
SILK 0.00 No Change ▼ 0.00 (0%)
SNGP 0.00 No Change ▼ 0.00 (0%)
TELE 0.00 No Change ▼ 0.00 (0%)
TRG 0.00 No Change ▼ 0.00 (0%)
UNITY 0.00 Decreased By ▼ -29.35 (-100%)
WTL 0.00 No Change ▼ 0.00 (0%)
BR100 4,644 Decreased By ▼ -89.39 (-1.89%)
BR30 20,295 Decreased By ▼ -44.64 (-0.22%)
KSE100 45,348 Decreased By ▼ -196.27 (-0.43%)
KSE30 17,729 Decreased By ▼ -82.34 (-0.46%)
World

German vaccine official: rare clots after AstraZeneca shots were 20 times higher

  • His comments came as the European Medicines Agency and Britain's medical regulator acknowledged a possible link between the AstraZeneca vaccine to very rare cases of unusual blood clots with low blood platelets, with most cases reported in women under 60 years of age within two weeks of vaccination.
Updated 07 Apr 2021

BERLIN: Instances of rare clotting in people who got AstraZeneca's COVID-19 vaccine were 20 times higher than would be likely in the same time period among a specific age group, Christian Bogdan, a member of Germany's vaccine committee, said on Wednesday.

His comments came as the European Medicines Agency and Britain's medical regulator acknowledged a possible link between the AstraZeneca vaccine to very rare cases of unusual blood clots with low blood platelets, with most cases reported in women under 60 years of age within two weeks of vaccination.

Regulators said the benefits of the AstraZeneca shot still outweigh risks.

Comments

Comments are closed.